Nearly 28 million Americans have been told their cholesterol is normal. Their triglycerides say otherwise.

Among adults with a normal cholesterol diagnosis and total cholesterol below 200 mg/dL, 11.4% have fasting triglycerides at or above 150 mg/dL. That translates to an estimated 27,960,795 people walking away from their annual labs with a clean bill of cardiovascular health that may not be clean at all.

The Gap Between "Normal Cholesterol" and Actual Cardiovascular Risk

Total cholesterol below 200 mg/dL is the standard threshold clinicians use to reassure patients. But triglycerides are a separate metabolic signal, and they're not captured in that single number. Among adults who have never been told they have high cholesterol, 8.6% have borderline triglycerides (150-199 mg/dL) and 7.7% have high triglycerides (200-499 mg/dL), representing 6.72 million and 5.98 million people respectively. Another 320,000 have very high triglycerides at or above 500 mg/dL, a level associated with acute pancreatitis risk, not just cardiovascular disease.

For comparison, adults who have been told they have high cholesterol show elevated triglycerides at roughly double the rate: 14.6% fall in the high range versus 7.7% among those never flagged. That gap makes sense. What's harder to explain away is the 16.7% of "never diagnosed" adults who still carry borderline or elevated triglycerides. These are people whose standard cholesterol panel gave no signal of a problem.

The consequence is straightforward: if a patient's total cholesterol comes back under 200 and their provider stops there, a meaningful share of those patients leave with incomplete information about their cardiovascular risk profile.

HDL Collapse in the "Normal" Group

The picture gets sharper when HDL enters the frame. Among adults with triglycerides at or above 150 mg/dL and total cholesterol below 200 mg/dL, 67.6% of women have low HDL (below 50 mg/dL). Among men in the same group, 52.8% fall below the 40 mg/dL threshold for low HDL.

The average HDL among men in this group is 39.9 mg/dL, just barely below the clinical cutoff. That's not a rounding error. That's a population whose average HDL sits at the floor of what's considered acceptable, and more than half of them are below it.

Women fare worse by percentage. Two-thirds of women with elevated triglycerides and ostensibly normal total cholesterol are also carrying low HDL. The combination of high triglycerides and low HDL is a core feature of metabolic syndrome and atherogenic dyslipidemia, a pattern that total cholesterol alone cannot detect. These women received a normal result. Their lipid panel, read more completely, tells a different story.

What a Single Number Misses

The standard cholesterol panel was designed for a different era of cardiovascular risk assessment. Total cholesterol below 200 mg/dL remains a useful population-level screen, but the data here illustrate its limits at the individual level.

Adults told they have high cholesterol have normal triglycerides 68.2% of the time, compared to 83.3% among those never diagnosed. That 15-point gap confirms that high cholesterol and high triglycerides are related but distinct conditions. Treating one as a proxy for the other leaves a detectable fraction of the population unscreened for a separate and clinically significant risk factor.

The 83.3% of never-diagnosed adults with normal triglycerides (64.73 million people) are genuinely fine on this measure. The problem is the 16.7% who aren't, and who have no reason to think otherwise.

Given that 67.6% of women with triglycerides at or above 150 mg/dL and total cholesterol below 200 mg/dL also have low HDL, what proportion of those 27.9 million people are receiving any follow-up cardiovascular risk assessment beyond the normal cholesterol result they were handed on their way out the door?